Selected research
Industry Growth & Trends
Global Fibrin Sealant (Human) Industry Growth and Trends Forecast to 2032
Market perspective
The global Fibrin Sealant (Human) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Fibrin Sealant (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Fibrin Sealant (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fibrin Sealant (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fibrin Sealant (Human) include Behringwerke, CSL, Grifols, Immuno, Octapharma, Baxter, Bayer, Hualan Biological and Shanghai RAAS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Fibrin Sealant (Human) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Fibrin Sealant (Human) market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fibrin Sealant (Human) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fibrin Sealant (Human).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Fibrin Sealant (Human) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Fibrin Sealant (Human) Market by Company
Behringwerke
CSL
Grifols
Immuno
Octapharma
Baxter
Bayer
Hualan Biological
Shanghai RAAS
Fibrin Sealant (Human) Segment by Type
2mL/Set
4mL/Set
10mL/Set
Fibrin Sealant (Human) Segment by Application
Hospital
Clinic
Other
Fibrin Sealant (Human) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibrin Sealant (Human) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fibrin Sealant (Human) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibrin Sealant (Human).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fibrin Sealant (Human) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Fibrin Sealant (Human) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2mL/Set
- 4mL/Set
- 10mL/Set
Applications
- Hospital
- Clinic
- Other
Companies covered
- Behringwerke
- CSL
- Grifols
- Immuno
- Octapharma
- Baxter
- Bayer
- Hualan Biological
- Shanghai RAAS
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Fibrin Sealant (Human) Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Fibrin Sealant (Human) Sales Estimates and Forecasts (2021-2032)
- 1.3 Fibrin Sealant (Human) Market by Type
- 1.3.1 2mL/Set
- 1.3.2 4mL/Set
- 1.3.3 10mL/Set
- 1.4 Global Fibrin Sealant (Human) Market Size by Type
- 1.4.1 Global Fibrin Sealant (Human) Market Size Overview by Type (2021-2032)
- 1.4.2 Global Fibrin Sealant (Human) Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Fibrin Sealant (Human) Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Fibrin Sealant (Human) Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Fibrin Sealant (Human) Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Fibrin Sealant (Human) Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Fibrin Sealant (Human) Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Fibrin Sealant (Human) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Fibrin Sealant (Human) Industry Trends
- 2.2 Fibrin Sealant (Human) Industry Drivers
- 2.3 Fibrin Sealant (Human) Industry Opportunities and Challenges
- 2.4 Fibrin Sealant (Human) Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Fibrin Sealant (Human) Revenue (2021-2026)
- 3.2 Global Top Players by Fibrin Sealant (Human) Sales (2021-2026)
- 3.3 Global Top Players by Fibrin Sealant (Human) Price (2021-2026)
- 3.4 Global Fibrin Sealant (Human) Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fibrin Sealant (Human) Major Company Production Sites & Headquarters
- 3.6 Global Fibrin Sealant (Human) Company, Product Type & Application
- 3.7 Global Fibrin Sealant (Human) Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fibrin Sealant (Human) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fibrin Sealant (Human) Players Market Share by Revenue in 2025
- 3.8.3 2025 Fibrin Sealant (Human) Tier 1, Tier 2, and Tier 3
4 Fibrin Sealant (Human) Regional Status and Outlook
- 4.1 Global Fibrin Sealant (Human) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Fibrin Sealant (Human) Historic Market Size by Region
- 4.2.1 Global Fibrin Sealant (Human) Sales in Volume by Region (2021-2026)
- 4.2.2 Global Fibrin Sealant (Human) Sales in Value by Region (2021-2026)
- 4.2.3 Global Fibrin Sealant (Human) Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Fibrin Sealant (Human) Forecasted Market Size by Region
- 4.3.1 Global Fibrin Sealant (Human) Sales in Volume by Region (2027-2032)
- 4.3.2 Global Fibrin Sealant (Human) Sales in Value by Region (2027-2032)
- 4.3.3 Global Fibrin Sealant (Human) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fibrin Sealant (Human) by Application
- 5.1 Fibrin Sealant (Human) Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Fibrin Sealant (Human) Market Size by Application
- 5.2.1 Global Fibrin Sealant (Human) Market Size Overview by Application (2021-2032)
- 5.2.2 Global Fibrin Sealant (Human) Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Fibrin Sealant (Human) Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Fibrin Sealant (Human) Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Fibrin Sealant (Human) Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Fibrin Sealant (Human) Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Fibrin Sealant (Human) Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Fibrin Sealant (Human) Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Behringwerke
- 6.1.1 Behringwerke Company Information
- 6.1.2 Behringwerke Business Overview
- 6.1.3 Behringwerke Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Behringwerke Fibrin Sealant (Human) Product Portfolio
- 6.1.5 Behringwerke Recent Developments
- 6.2 CSL
- 6.2.1 CSL Company Information
- 6.2.2 CSL Business Overview
- 6.2.3 CSL Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 CSL Fibrin Sealant (Human) Product Portfolio
- 6.2.5 CSL Recent Developments
- 6.3 Grifols
- 6.3.1 Grifols Company Information
- 6.3.2 Grifols Business Overview
- 6.3.3 Grifols Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Grifols Fibrin Sealant (Human) Product Portfolio
- 6.3.5 Grifols Recent Developments
- 6.4 Immuno
- 6.4.1 Immuno Company Information
- 6.4.2 Immuno Business Overview
- 6.4.3 Immuno Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Immuno Fibrin Sealant (Human) Product Portfolio
- 6.4.5 Immuno Recent Developments
- 6.5 Octapharma
- 6.5.1 Octapharma Company Information
- 6.5.2 Octapharma Business Overview
- 6.5.3 Octapharma Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Octapharma Fibrin Sealant (Human) Product Portfolio
- 6.5.5 Octapharma Recent Developments
- 6.6 Baxter
- 6.6.1 Baxter Company Information
- 6.6.2 Baxter Business Overview
- 6.6.3 Baxter Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Baxter Fibrin Sealant (Human) Product Portfolio
- 6.6.5 Baxter Recent Developments
- 6.7 Bayer
- 6.7.1 Bayer Company Information
- 6.7.2 Bayer Business Overview
- 6.7.3 Bayer Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Bayer Fibrin Sealant (Human) Product Portfolio
- 6.7.5 Bayer Recent Developments
- 6.8 Hualan Biological
- 6.8.1 Hualan Biological Company Information
- 6.8.2 Hualan Biological Business Overview
- 6.8.3 Hualan Biological Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Hualan Biological Fibrin Sealant (Human) Product Portfolio
- 6.8.5 Hualan Biological Recent Developments
- 6.9 Shanghai RAAS
- 6.9.1 Shanghai RAAS Company Information
- 6.9.2 Shanghai RAAS Business Overview
- 6.9.3 Shanghai RAAS Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Shanghai RAAS Fibrin Sealant (Human) Product Portfolio
- 6.9.5 Shanghai RAAS Recent Developments
7 North America by Country
- 7.1 North America Fibrin Sealant (Human) Sales by Country
- 7.1.1 North America Fibrin Sealant (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Fibrin Sealant (Human) Sales by Country (2021-2026)
- 7.1.3 North America Fibrin Sealant (Human) Sales Forecast by Country (2027-2032)
- 7.2 North America Fibrin Sealant (Human) Market Size by Country
- 7.2.1 North America Fibrin Sealant (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Fibrin Sealant (Human) Market Size by Country (2021-2026)
- 7.2.3 North America Fibrin Sealant (Human) Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Fibrin Sealant (Human) Sales by Country
- 8.1.1 Europe Fibrin Sealant (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Fibrin Sealant (Human) Sales by Country (2021-2026)
- 8.1.3 Europe Fibrin Sealant (Human) Sales Forecast by Country (2027-2032)
- 8.2 Europe Fibrin Sealant (Human) Market Size by Country
- 8.2.1 Europe Fibrin Sealant (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Fibrin Sealant (Human) Market Size by Country (2021-2026)
- 8.2.3 Europe Fibrin Sealant (Human) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Fibrin Sealant (Human) Sales by Country
- 9.1.1 Asia-Pacific Fibrin Sealant (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Fibrin Sealant (Human) Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Fibrin Sealant (Human) Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Fibrin Sealant (Human) Market Size by Country
- 9.2.1 Asia-Pacific Fibrin Sealant (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Fibrin Sealant (Human) Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Fibrin Sealant (Human) Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Fibrin Sealant (Human) Sales by Country
- 10.1.1 South America Fibrin Sealant (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Fibrin Sealant (Human) Sales by Country (2021-2026)
- 10.1.3 South America Fibrin Sealant (Human) Sales Forecast by Country (2027-2032)
- 10.2 South America Fibrin Sealant (Human) Market Size by Country
- 10.2.1 South America Fibrin Sealant (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Fibrin Sealant (Human) Market Size by Country (2021-2026)
- 10.2.3 South America Fibrin Sealant (Human) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Fibrin Sealant (Human) Sales by Country
- 11.1.1 Middle East and Africa Fibrin Sealant (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Fibrin Sealant (Human) Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Fibrin Sealant (Human) Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Fibrin Sealant (Human) Market Size by Country
- 11.2.1 Middle East and Africa Fibrin Sealant (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Fibrin Sealant (Human) Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Fibrin Sealant (Human) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Fibrin Sealant (Human) Value Chain Analysis
- 12.1.1 Fibrin Sealant (Human) Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Fibrin Sealant (Human) Production Mode & Process
- 12.2 Fibrin Sealant (Human) Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Fibrin Sealant (Human) Distributors
- 12.2.3 Fibrin Sealant (Human) Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst